Hangzhou Minsheng Healthcare Co Ltd - Class A Shares

SZSE:301507 (China)   Class A Shares
Â¥ 12.88 (-2.28%) May 23
51.52
P/B:
3.00
Market Cap:
Â¥ 4.59B ($ 633.84M)
Enterprise V:
Â¥ 3.90B ($ 538.67M)
Volume:
2.93M
Avg Vol (2M):
4.47M
Volume:
2.93M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Hangzhou Minsheng Healthcare Co Ltd ( ) from 2023 to May 23 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Hangzhou Minsheng Healthcare stock (SZSE:301507) PE ratio as of May 23 2024 is 51.52. More Details

Hangzhou Minsheng Healthcare Co Ltd (SZSE:301507) PE Ratio (TTM) Chart

To

Hangzhou Minsheng Healthcare Co Ltd (SZSE:301507) PE Ratio (TTM) Historical Data

Total 170
  • 1
  • 2
Hangzhou Minsheng Healthcare PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-23 51.5 2024-03-14 45.9
2024-05-22 52.7 2024-03-13 46.4
2024-05-21 51.9 2024-03-12 46.6
2024-05-20 52.6 2024-03-11 45.4
2024-05-17 52.8 2024-03-08 44.5
2024-05-16 52.4 2024-03-07 44.5
2024-05-15 52.4 2024-03-06 45.0
2024-05-14 53.2 2024-03-05 44.7
2024-05-13 52.7 2024-03-04 46.5
2024-05-10 53.7 2024-03-01 45.9
2024-05-09 55.1 2024-02-29 45.8
2024-05-08 55.6 2024-02-28 44.3
2024-05-07 56.4 2024-02-27 48.2
2024-05-06 53.1 2024-02-26 47.2
2024-04-30 51.1 2024-02-23 47.8
2024-04-29 49.8 2024-02-22 43.6
2024-04-26 49.0 2024-02-21 42.8
2024-04-25 49.1 2024-02-20 42.5
2024-04-24 48.2 2024-02-19 41.5
2024-04-23 46.4 2024-02-08 40.3
2024-04-22 45.3 2024-02-07 37.8
2024-04-19 45.2 2024-02-06 40.2
2024-04-18 45.7 2024-02-05 37.6
2024-04-17 46.5 2024-02-02 41.5
2024-04-16 43.4 2024-02-01 44.1
2024-04-15 47.4 2024-01-31 45.0
2024-04-12 51.2 2024-01-30 47.5
2024-04-11 49.3 2024-01-29 49.7
2024-04-10 49.2 2024-01-26 50.3
2024-04-09 50.8 2024-01-25 50.5
2024-04-08 49.0 2024-01-24 48.5
2024-04-03 50.6 2024-01-23 47.6
2024-04-02 51.3 2024-01-22 47.3
2024-04-01 51.6 2024-01-19 50.8
2024-03-29 49.6 2024-01-18 51.8
2024-03-28 49.7 2024-01-17 52.4
2024-03-27 42.5 2024-01-16 53.7
2024-03-26 43.3 2024-01-15 54.6
2024-03-25 43.6 2024-01-12 54.6
2024-03-22 45.1 2024-01-11 55.1
2024-03-21 46.9 2024-01-10 54.0
2024-03-20 47.3 2024-01-09 54.4
2024-03-19 46.6 2024-01-08 54.5
2024-03-18 46.9 2024-01-05 57.2
2024-03-15 46.2 2024-01-04 56.6

Hangzhou Minsheng Healthcare Co Ltd (SZSE:301507) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Hangzhou Minsheng Healthcare Co Ltd focuses on the field of vitamin and mineral supplements and is a high-tech enterprise integrating research and development, production and sales of vitamin and mineral over-the-counter drugs and health food. The company's current main product is 21 Golden Vita multi-dimensional element tablets (21).